Bristol-Myers Squibb Co. (BMY) Misses Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $59.12 -0.77%
Revenue Growth %: +3.4%
Financial Fact:
Net Earnings: 1.22B
Today's EPS Names:
HOVR, VFS, PGR, More
Revenue Growth %: +3.4%
Financial Fact:
Net Earnings: 1.22B
Today's EPS Names:
HOVR, VFS, PGR, More
Join SI Premium – FREE
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q2 EPS of $0.48, $0.01 worse than the analyst estimate of $0.49. Revenue for the quarter came in at $4.44 billion versus the consensus estimate of $4.44 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Top AI Semiconductor Stocks According to Stifel Analysis
- Bernstein SocGen: 'MediaTek Inc. (2454:TT) (MDTKF) is our Top Pick and the recent pullback provides a good setup'
- SpaceX's spectrum deal puts SIRI's satellite assets in focus
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
